Skyepharma Regulatory News (SKP)

SKYEPHARMA PLC - RESULT OF AGM

LONDON, UK, 16 May 2012 - SkyePharma PLC (LSE: SKP) announces the results of the voting by shareholders at the Annual General Meeting held earlier today.  Allresolutions were passed with the requisite majorities on a show of hands.

In accordance with Listing Rule 9.6.2, a copy of the resolutions passed, other than resolutions concerning ordinary business, will shortly be submitted to the National Storage Mechanism, and will be available for inspection at www.morningstar.co.uk/uk/NSM

The full text of all the resolutions passed at the meeting can be found in the Notice of Annual General Meeting, which is available for inspection at www.morningstar.co.uk/uk/NSM and on the Company's website at www.skyepharma.com.

Full details of the proxy voting will be available on our website (www.skyepharma.com) later today.

For further information please contact:

About SkyePharma PLC

Using its multiple drug delivery technologies and expertise, SkyePharma creates enhanced versions

of pharmaceutical products. The Group has eleven approved products in the areas of oral and topical

delivery as well as important license and revenue-generating arrangements in inhalation and

injectable technologies. The Group's products are marketed throughout the world by leading

pharmaceutical companies. For more information, visit www.skyepharma.com.